Wednesday, February 10, 2010, 12:20PM AEST - The Australian Stockmarket closes in 3 hours and 45 minutes.
To create a watchlist or portfolio of shares, Register

Cadence Pharmaceuticals Inc. (CADX)

 8:00AM AEST: 10.34 USD  Up 0.45 (4.55%)  
 MORE ON CADX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Cadence Pharmaceuticals, Inc. (NGM:CADX) Delayed quote dataEdit
Last Trade:10.34 USD
Trade Time: 8:00AM AEST
Change:Up 0.45 (4.55%)
Prev Close:9.89
Open:9.99
Bid:9.09 x 300
Ask:N/A
1y Target Est:13.00
Day's Range:9.88 - 10.35
52wk Range:5.68 - 12.68
Volume:652,616
Avg Vol (3m):374,216
Market Cap:521.66M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add CADX to Portfolio   Download Data

 HEADLINES 
•Monday Options Recap: Volatility Eases
at Seeking Alpha (Tue 7:55AM)
•[$$] A Pain-Free Investment
at RealMoney by TheStreet.com (Wed, Jan 20)
•Cadence Pharma downgraded by Oppenheimer
Briefing.com (Mon, Nov 16)
•[$$] Small Stocks Gain on Week
at The Wall Street Journal Online (Sat, Nov 14)
•CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Sat, Nov 14)
•FDA Delays Cadence Drug Review: BioBuzz
at TheStreet.com (Sat, Nov 14)
•FDA extends review of Cadence's IV drug Acetavance
AP (Sat, Nov 14)
•Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
PR Newswire (Fri, Nov 13)
•CADENCE PHARMACEUTICALS INC Financials
EDGAR Online Financials (Thu, Nov 12)
•3 Companies Looking for Gratitude Early
at Motley Fool (Wed, Nov 11)
•CADENCE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
EDGAR Online (Fri, Nov 6)
More Headlines for CADX...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.95
EPS Est (in 2 years) (Dec-10) :-1.27
Avg Rec (current)*:2.1
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices